Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (`Iressa', ZD1839)

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical and Experimental Metastasis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/B:CLIN.0000037697.76011.1dPMID 15387370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy

  2004cited by this paper
• Mechanisms of tamoxifen resistance.

  2004cited by this paper
• Growth Factor Network Disruption in Prostate Cancer Progression

  2004cited by this paper
• Mechanisms of tamoxifen resistance

  2004cited by this paper
• Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).

  2003cited by this paper
• Epidermal growth factor increased the expression of alpha2beta1-integrin and modulated integrin-mediated signaling in human cervical adenocarcinoma cells.

  2003cited by this paper
• Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.

  2003influential reference
• Epidermal growth factor receptor: mechanisms of activation and signalling.

  2003cited by this paper
• Endocrine-responsive breast cancer and strategies for combating resistance

  2002cited by this paper
• Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

  2002cited by this paper
• Dual Inhibition of Focal Adhesion Kinase and Epidermal Growth Factor Receptor Pathways Cooperatively Induces Death Receptor-mediated Apoptosis in Human Breast Cancer Cells*

  2002cited by this paper
• ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy.

  2002cited by this paper
• The Invasive Phenotype in HMT-3522 Cells Requires Increased EGF Receptor Signaling Through Both PI 3-Kinase and ERK 1,2 Pathways

  2002cited by this paper
• The Ras-Raf-MEK-ERK Pathway in the Treatment of Cancer

  2002cited by this paper
• Growth Factor-Induced Cell Motility in Tumor Invasion

  2002cited by this paper
• Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion

  2001cited by this paper
• Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration

  2001cited by this paper
• Adhesion, actin cytoskeleton organisation and the spreading of colon adenocarcinoma cells induced by EGF are mediated by α2β1 integrin low clustering through focal adhesion kinase

  2001cited by this paper
• Epidermal Growth Factor-Induced Tumor Cell Invasion and Metastasis Initiated by Dephosphorylation and Downregulation of Focal Adhesion Kinase

  2001cited by this paper
• EGFR and cancer prognosis.

  2001cited by this paper
• Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.

  2001cited by this paper
• Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

  2000cited by this paper
• Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4

  2000cited by this paper
• Co‐expression of epidermal growth factor receptor and transforming growth factor‐α predicts worse prognosis in breast‐cancer patients

  2000cited by this paper
• ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases

  2000cited by this paper
• Co-expression of epidermal growth factor receptor and transforming growth factor-alpha is independent of ras mutations in lung adenocarcinoma.

  2000cited by this paper
• ZD1839 ('Iressa') as an anticancer agent.

  2000cited by this paper
• Transfection of anti‐sense complementary DNA of human epidermal‐growth‐factor receptor attenuates the proliferation of human non‐small‐cell‐lung‐cancer cells

  1999cited by this paper
• Expression of transforming growth factor-alpha and epidermal growth factor receptor in gastrointestinal stromal tumours.

  1999cited by this paper
• Epidermal growth factor receptor relocalization and kinase activity are necessary for directional migration of keratinocytes in DC electric fields.

  1999cited by this paper
• Activation of extracellular signal-regulated kinase in human prostate cancer.

  1999cited by this paper
• Expression of transforming growth factor-α and epidermal growth factor receptor in gastrointestinal stromal tumours

  1999cited by this paper
• EGF receptor.

  1999cited by this paper
• The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase.

  1999cited by this paper
• Overexpression of EGFR and c‐erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts

  1998cited by this paper
• Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

  1998cited by this paper
• Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

  1998cited by this paper
• Hyperexpression of mitogen-activated protein kinase in human breast cancer.

  1997cited by this paper
• Overexpression of the Epidermal Growth Factor Receptor Contributes to Enhanced Ligand-Mediated Motility in Keratinocyte Cell Lines1.

  1997cited by this paper
• Overexpression of the epidermal growth factor receptor contributes to enhanced ligand-mediated motility in keratinocyte cell lines.

  1997cited by this paper
• Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro.

  1997cited by this paper
• Induction of apoptosis by EGF receptor in rat mammary adenocarcinoma cells coincides with enhanced spontaneous tumour metastasis.

  1996cited by this paper
• Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.

  1995cited by this paper
• Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.

  1994cited by this paper
• Transformation of mammalian cells by constitutively active MAP kinase kinase.

  1994cited by this paper
• Regulation of the MAP kinase cascade.

  1994cited by this paper
• Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration.

  1993cited by this paper
• Quantitative determination of EGF-R during epidermal wound healing.

  1992cited by this paper
• Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line.

  1992cited by this paper
• Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly

  1992cited by this paper
• Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-α

  1978cited by this paper

• Mechanical Disruption by Focused Ultrasound Re-sensitizes ER+ Breast Cancer Cells to Hormone Therapy.

  2024cites this paper
• Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer

  2024cites this paper
• Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies

  2023influential citation
• Biosynthesis of Artemisia abyssinica Leaf Extract-Mediated Bimetallic ZnO–CuO Nanoparticles: Antioxidant, Anticancer, and Molecular Docking Studies

  2023cites this paper
• The Efficient Activity of Glabridin and its Derivatives Against EGFR-mediated Inhibition of Breast Cancer.

  2023cites this paper
• LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER− breast cancer samples

  2023cites this paper
• Single-Cell Image-Based Analysis Reveals Chromatin Changes during the Acquisition of Tamoxifen Drug Resistance

  2022cites this paper
• FoxO3a Inhibits Tamoxifen-Resistant Breast Cancer Progression by Inducing Integrin α5 Expression

  2022cites this paper
• Nafamostat mesylate overcomes endocrine resistance of breast cancer through epigenetic regulation of CDK4 and CDK6 expression

  2021cites this paper
• YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ERα.

  2021cites this paper
• HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer

  2021cites this paper
• Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

  2020cites this paper
• Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti‐ALCAM scFv on breast cancer cells

  2020cites this paper
• Coordinate Enhancer Reprogramming by GATA3 and AP1 Promotes Phenotypic Plasticity to Achieve Breast Cancer Endocrine Resistance

  2019cites this paper
• Post-translational Mechanisms of Zinc Signalling in Cancer

  2019cites this paper
• On an Interpolation Problem for Generalized Schur Functions

  2019cites this paper
• Co-Administration of Fish Oil With Signal Transduction Inhibitors Has Anti-Migration Effects in Breast Cancer Cell Lines, in vitro

  2018cites this paper
• Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3β/Snail signaling

  2018cites this paper
• A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382

  2018cites this paper
• Proteomic Characterization of Plasma Cells from Patients with Multiple Myeloma

  2018cites this paper
• Understanding how targeting zinc transporters prevents the development of aggressive cancer

  2018cites this paper
• The role of sex hormones and steroid receptors on female reproductive cancers.

  2017cites this paper
• Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer

  2017cites this paper
• Invasion and metastasis of tumour cells resistant to chemotherapy.

  2017cites this paper
• Exploring the impact of anti-oestrogen resistance on the capacity of breast cancer cells to modulate bone cell function and their sensitivity to bisphosphonates

  2017cites this paper
• Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro

  2016cites this paper
• Stress chaperone mortalin contributes to epithelial-mesenchymal transition and cancer metastasis.

  2016cites this paper
• Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement.

  2016cites this paper
• Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance

  2016cites this paper
• Emerging Role and Targeting of Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) in Human Malignancies

  2015cites this paper
• Protein Kinase CK2 Cellular Function in Normal and Disease States

  2015cites this paper
• The molecular landscape of premenopausal breast cancer

  2015cites this paper
• The role of reproductive hormones in epithelial ovarian carcinogenesis.

  2015cites this paper
• Glucocorticoid Receptor Function and its Role in Tamoxifen Resistance

  2015cites this paper
• Breast Cancer and Oxidative Stress

  2015influential citation
• MicroRNA-200c as a Prognostic Biomarker for Pancreatic Cancer.

  2015cites this paper
• Cellular Zinc Signalling Is Triggered by CK2

  2015cites this paper
• The exploration of CD44 as a mediator of a drug resistant phenotype in ER+ breast cancer

  2015cites this paper
• The role of captopril and losartan in prevention and regression of tamoxifen-induced resistance of breast cancer cell line MCF-7: an in vitro study.

  2014cites this paper
• Zinc Signaling and Cancer

  2014cites this paper
• Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.

  2014influential citation
• Signaling and Antiestrogen Resistance and BCAR 3 Scaffolding Proteins in Cell ( BCAR 1 ) Antiestrogen Resistance Protein 1 Association of the Breast Cancer Signal Transduction

  2014cites this paper
• Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro

  2014cites this paper
• Association of the Breast Cancer Antiestrogen Resistance Protein 1 (BCAR1) and BCAR3 Scaffolding Proteins in Cell Signaling and Antiestrogen Resistance*

  2014cites this paper
• ER-α36: a novel biomarker and potential therapeutic target in breast cancer

  2014influential citation
• Cx43 reverses the resistance of A549 lung adenocarcinoma cells to cisplatin by inhibiting EMT.

  2014cites this paper
• Zinc Signals in Cellular Functions and Disorders

  2014cites this paper
• eR- α 36: a novel biomarker and potential therapeutic target in breast cancer

  2014cites this paper
• Global characterization of signalling networks associated with tamoxifen resistance in breast cancer

  2013cites this paper
• Estrogen receptor‐α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells

  2013cites this paper
• Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d'un nou subtipus de càncer de mama (Basal/ErbB2+)

  2013cites this paper
• Tamoxifen‐resistant breast cancer cells possess cancer stem‐like cell properties

  2013cites this paper
• Profilin 1: Do we have a novel proteome‐found biomarker predicting response to anticancer therapy?

  2013cites this paper
• Activation of snail and EMT-like signaling via the IKKαβ/NF-κB pathway in Apicidin-resistant HA22T hepatocellular carcinoma cells.

  2013cites this paper
• The Exposure of Breast Cancer Cells to Fulvestrant and Tamoxifen Modulates Cell Migration Differently

  2013cites this paper
• Establishment of animal model for the analysis of cancer cell metastasis during radiotherapy

  2012cites this paper
• CK 20 Expression Enhances the Invasiveness of Tamoxifen-resistant MCF-7 Cells

  2012cites this paper
• CK20 expression enhances the invasiveness of tamoxifen-resistant MCF-7 cells.

  2012cites this paper
• Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan

  2012cites this paper
• Acquired tamoxifen resistance and promotion of angiogenic responses in breast cancer

  2012cites this paper
• Hormone response in ovarian cancer: time to reconsider as a clinical target?

  2012cites this paper
• Tamoxifen resistance in breast cancer : a proteomic approach

  2012cites this paper
• NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

  2012cites this paper
• A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer

  2012cites this paper
• Identification of Lyn kinase as a therapeutic target fortamoxifen resistant breast cancer

  2012cites this paper
• Protein kinase CK 2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP 7

  2012cites this paper
• Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

  2012cites this paper
• Protein Kinase CK2 Triggers Cytosolic Zinc Signaling Pathways by Phosphorylation of Zinc Channel ZIP7

  2012cites this paper
• Mechanism of the Mesenchymal–Epithelial Transition and Its Relationship with Metastatic Tumor Formation

  2011cites this paper
• MicroRNA-mediated drug resistance in breast cancer

  2011cites this paper
• Targeting Cas Family Proteins as a Novel Treatment for Breast Cancer

  2011cites this paper
• Acquired endocrine resistance in breast cancer: implications for tumour metastasis.

  2011cites this paper
• erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

  2011cites this paper
• Cancer Stem Cells and Side Population Cells in Breast Cancer and Metastasis

  2011cites this paper
• (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.

  2011cites this paper
• Stem cells: their role in breast cancer development and resistance to treatment.

  2011cites this paper
• Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.

  2011cites this paper
• Breast Cancer Stem Cells and Their Role in Resistance to Endocrine Therapy

  2011cites this paper
• Resistance to Endocrine Therapy in Breast Cancer: Are Breast Cancer Stem Cells Implicated?

  2011cites this paper
• Src kinase: a therapeutic opportunity in endocrine-responsive and resistant breast cancer

  2011cites this paper
• Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance

  2011cites this paper
• The dual kinase complex FAK-Src as a promising therapeutic target in cancer

  2010cites this paper
• Understanding acquired resistance to Lapatinib in breast cancer cells

  2010cites this paper
• [The role of epithelial-mesenchymal transition in the gastroenterology].

  2010cites this paper
• The dual kinase complex FAK-Src as a promising therapeutic target in cancer

  2010cites this paper
• Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells.

  2010cites this paper
• Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients.

  2010cites this paper
• The role of E-cadherin in colon cancer drug resistance

  2010influential citation
• The dual kinase complex FAK-Src as a promising therapeutic target in cancer

  2010cites this paper
• Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells

  2009cites this paper
• Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.

  2009cites this paper
• Adverse Features of Acquired Antihormone Resistance and Their Targeting

  2009cites this paper
• Osteoblasts suppress high bone turnover caused by osteolytic breast cancer in-vitro.

  2009cites this paper
• Involvement of Pin1 induction in epithelial–mesenchymal transition of tamoxifen‐resistant breast cancer cells

  2009cites this paper
• Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.

  2009cites this paper
• Pro-invasive role of MMP-9 and c-Met in faslodex-resistant breast cancer

  2009cites this paper
• The dark side of antihormonal action in breast cancer

  2009influential citation
• Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits?

  2009cites this paper
• The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies

  2009cites this paper
• Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells

  2009cites this paper